{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:09:11Z","timestamp":1793750951465,"version":"4.6.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","aaojournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.ophtha.2015.01.016","type":"journal-article","created":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T06:33:26Z","timestamp":1425450806000},"page":"1262-1268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis"],"prefix":"10.1016","volume":"122","author":[{"given":"Lavnish","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Tanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"McAdoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Medjeral-Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon R.J.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurpreet","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth M.","family":"Tarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Pusey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Lightman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2015.01.016_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2015.01.016_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2015.01.016_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A\u00a0randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2015.01.016_bib4","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.V95842","article-title":"Relapse rate, renal survival, and cancer morbidity in patients with Wegener\u2019s granulomatosis or microscopic polyangiitis with renal involvement","volume":"9","author":"Westman","year":"1998","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"Suppl 1","key":"10.1016\/j.ophtha.2015.01.016_bib5","first-page":"29","article-title":"European therapeutic trials in ANCA-associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials. European Community Study Group on Clinical Trials in Systemic Vasculitis ECSYSVASTRIAL","volume":"101","author":"ECSYSVASTRIAL","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ophtha.2015.01.016_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneph.2013.225","article-title":"Treatment of ANCA-associated vasculitis","volume":"10","author":"Schonermarck","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ophtha.2015.01.016_bib7","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1136\/ard.2010.130203","article-title":"Prospective long-term follow-up of patients with localised Wegener\u2019s granulomatosis: does it occur as persistent disease stage?","volume":"69","author":"Holle","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ophtha.2015.01.016_bib8","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.4049\/jimmunol.125.4.1678","article-title":"Characterization of a human B lymphocyte-specific antigen","volume":"125","author":"Stashenko","year":"1980","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ophtha.2015.01.016_bib9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nri2729","article-title":"Effector and regulatory B cells: modulators of CD4(+) T cell immunity","volume":"10","author":"Lund","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ophtha.2015.01.016_bib10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ana.21363","article-title":"Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial","volume":"63","author":"Bar-Or","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ophtha.2015.01.016_bib11","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/rheumatology\/kei080","article-title":"B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients","volume":"44","author":"Leandro","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ophtha.2015.01.016_bib12","first-page":"20","article-title":"Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial","volume":"35","author":"Mease","year":"2008","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ophtha.2015.01.016_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2015.01.016_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2015.01.016_bib15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11926-010-0138-6","article-title":"Pathophysiology of ANCA-associated small vessel vasculitis","volume":"12","author":"Kallenberg","year":"2010","journal-title":"Curr Rheumatol Rep"},{"issue":"Suppl 2","key":"10.1016\/j.ophtha.2015.01.016_bib16","first-page":"SII40","article-title":"Granuloma formation, implications for the pathogenesis of vasculitis","volume":"69","author":"Sneller","year":"2002","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.ophtha.2015.01.016_bib17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000072987","article-title":"The Th1 and Th2 paradigm in ANCA-associated vasculitis","volume":"26","author":"Sanders","year":"2003","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.ophtha.2015.01.016_bib18","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/1529-0131(199904)42:4<742::AID-ANR18>3.0.CO;2-I","article-title":"Cytokine profiles in Wegener\u2019s granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation","volume":"42","author":"Csernok","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2015.01.016_bib19","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/art.24637","article-title":"A\u00a0multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis","volume":"60","author":"Jones","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2015.01.016_bib20","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1016\/j.ophtha.2011.06.009","article-title":"Rituximab in refractory ophthalmic Wegener\u2019s granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective","volume":"118","author":"Joshi","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2015.01.016_bib21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/ard.2011.153601","article-title":"Rituximab for refractory granulomatosis with polyangiitis (Wegener\u2019s granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations","volume":"71","author":"Holle","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ophtha.2015.01.016_bib22","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.2006.062711","article-title":"EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"66","author":"Hellmich","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ophtha.2015.01.016_bib23","first-page":"31","article-title":"Development and validation of a disease extent index for Wegener\u2019s granulomatosis","volume":"55","author":"de Groot","year":"2001","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.ophtha.2015.01.016_bib24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.01.016_bib25","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.ophtha.2013.12.003","article-title":"Clinical and imaging features predictive of orbital granulomatosis with polyangiitis and the risk of systemic involvement","volume":"121","author":"Tan","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2015.01.016_bib26","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ajo.2004.12.009","article-title":"Improving the reporting of clinical case series","volume":"139","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.01.016_bib27","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/art.21617","article-title":"Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis","volume":"54","author":"Leandro","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2015.01.016_bib28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","article-title":"Depletion of B cells in\u00a0vivo by a chimeric mouse human monoclonal antibody to CD20","volume":"83","author":"Reff","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.ophtha.2015.01.016_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0966-3274(03)00059-5","article-title":"Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys","volume":"12","author":"Schroder","year":"2003","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.ophtha.2015.01.016_bib30","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1002\/art.24903","article-title":"Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjogren\u2019s syndrome","volume":"60","author":"Pijpe","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2015.01.016_bib31","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/ard.2008.092791","article-title":"Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation","volume":"68","author":"Teng","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ophtha.2015.01.016_bib32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrrheum.2012.188","article-title":"Maintenance of clinical remission in ANCA-associated vasculitis","volume":"9","author":"Luqmani","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ophtha.2015.01.016_bib33","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.ophtha.2013.11.032","article-title":"Outcomes of changing immunosuppressive therapy after treatment failure in patients with noninfectious uveitis","volume":"121","author":"Joshi","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2015.01.016_bib34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1440-1673.2008.01930.x","article-title":"Non-invasive prediction of the degree of liver fibrosis in patients with hepatitis C using an ultrasound contrast agent. A pilot study","volume":"52","author":"Searle","year":"2008","journal-title":"J\u00a0Med Imaging Radiat Oncol"},{"key":"10.1016\/j.ophtha.2015.01.016_bib35","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","article-title":"Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis","volume":"371","author":"Guillevin","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2015.01.016_bib36","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1002\/art.34562","article-title":"Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis","volume":"64","author":"Lionaki","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2015.01.016_bib37","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1093\/ndt\/gfr127","article-title":"Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis","volume":"26","author":"Mansfield","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ophtha.2015.01.016_bib38","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"150","author":"de Groot","year":"2009","journal-title":"Ann Intern Med"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164201500086X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164201500086X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T15:31:11Z","timestamp":1691508671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016164201500086X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S016164201500086X"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2015.01.016","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2015.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}